Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination

Status Recruiting

Clinical Trial Summary

A few studies have documented that some patients can be down-staged from an initially inoperable state to a potentially resectable state. Five-year survival in initially inoperable patients that ultimately come to a complete resection appears to be similar to patients who are resected at first presentation. The investigators goal is to assess the rate of conversion to complete resection in patients with initially inoperable liver-only metastases due to colorectal cancer after treatment with HAI of oxaliplatin with FOLFIRI and bevacuzimab systemic treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04003792
Study type	Interventional
Source	Rabin Medical Center
Contact	Eran Sadot, MD
Phone	+972-3-9376201
Email	eransadot@gmail.com
Status	Recruiting
Phase	Phase 2
Start date	January 1, 2020
Completion date	January 2022

View Details

See also
Status	Clinical Trial	Phase
Suspended	`NCT04108481` - Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer	Phase 1/Phase 2
Recruiting	`NCT03562234` - The CLiFF Study: Change in Liver Function and Fat in Pre-operative Chemotherapy for Colorectal Liver Metastases
Recruiting	`NCT03732235` - TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer
Recruiting	`NCT06126419` - Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration	N/A
Active, not recruiting	`NCT05616039` - I-FIGS Feasibility Study	N/A
Withdrawn	`NCT05175092` - Living Donor Liver Transplantation for CRC Liver Metastases	N/A
Recruiting	`NCT04798898` - Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation	N/A
Not yet recruiting	`NCT06053996` - Hepatopulmonary Radio-sterilization With Immunotherapy	N/A
Not yet recruiting	`NCT06071052` - TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens	N/A
Recruiting	`NCT04491929` - Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases
Not yet recruiting	`NCT06050200` - TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery	N/A
Enrolling by invitation	`NCT03444194` - Treatment Response Evaluation in Patients With Non-resectable Colorectal Liver Metastases A Feasibility Study	N/A
Not yet recruiting	`NCT05884723` - Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis	N/A
Not yet recruiting	`NCT06185556` - COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases	Phase 2/Phase 3
Recruiting	`NCT05755672` - On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
Recruiting	`NCT04595266` - Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease	Phase 2
Recruiting	`NCT04701281` - Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer	Phase 1/Phase 2
Recruiting	`NCT05775146` - SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases	Phase 2
Recruiting	`NCT06200831` - Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases	N/A
Active, not recruiting	`NCT04046445` - Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer	Phase 1

Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms